Drugs / FOLINORAL
last change Jan 2018 re-read 3 minutes ago

FOLINORAL

Developed for
autism spectrum disorder
Investigated by
Central Hospital, Nancy, France

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02551380 Oct 2015 → Jan 2018 autism spectrum disorder Central Hospital, Nancy, France Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FOLINORAL ClinicalTrials.gov intervention name — accepted as the source's own label NCT02551380 ↗